Fresenius SE Debt to Equity Ratio 2016-2023 | FSNUY

Current and historical debt to equity ratio values for Fresenius SE (FSNUY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Fresenius SE debt/equity for the three months ending September 30, 2023 was 0.00.
Fresenius SE Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2023-09-30 $49.03B $32.96B 1.49
2023-06-30 $49.05B $34.27B 1.43
2023-03-31 $47.64B $34.54B 1.38
2022-12-31 $46.57B $33.95B 1.37
2022-09-30 $46.50B $34.40B 1.35
2022-06-30 $46.91B $34.09B 1.38
2022-03-31 $47.73B $34.32B 1.39
2021-12-31 $50.49B $34.65B 1.46
2021-09-30 $50.58B $33.24B 1.52
2021-06-30 $51.23B $32.69B 1.57
2021-03-31 $49.98B $33.17B 1.51
2020-12-31 $46.40B $29.73B 1.56
2020-09-30 $49.24B $30.63B 1.61
2020-06-30 $46.58B $30.01B 1.55
2020-03-31 $46.35B $29.74B 1.56
2019-12-31 $45.28B $29.77B 1.52
2019-09-30 $44.55B $29.69B 1.50
2019-06-30 $44.45B $28.53B 1.56
2019-03-31 $44.47B $29.34B 1.52
2018-12-31 $48.77B $18.20B 2.68
2018-09-30 $47.56B $17.23B 2.76
2018-06-30 $48.42B $17.15B 2.82
2018-03-31 $48.70B $17.07B 2.85
2017-12-31 $35.51B $24.55B 1.45
2017-09-30 $37.53B $24.88B 1.51
2017-06-30 $35.06B $23.12B 1.52
2017-03-31 $34.63B $23.36B 1.48
2016-12-31 $28.80B $22.60B 1.28
2016-09-30 $27.65B $21.12B 1.31
2016-06-30 $28.65B $20.85B 1.37
2016-03-31 $26.96B $19.87B 1.36
2015-12-31 $27.95B $19.99B 1.40
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.827B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $16.063B 16.60
DaVita (DVA) United States $11.923B 14.81
Encompass Health (EHC) United States $8.608B 22.03
Chemed (CHE) United States $8.132B 25.20
Elanco Animal Health (ELAN) United States $6.597B 17.11
Option Care Health (OPCH) United States $5.235B 19.82
RadNet (RDNT) United States $4.632B 96.45
Amedisys (AMED) United States $3.202B 22.68
Astrana Health (ASTH) United States $2.666B 36.05
Addus HomeCare (ADUS) United States $2.179B 28.20
LifeStance Health (LFST) United States $2.095B 0.00
U.S Physical Therapy (USPH) United States $1.424B 38.10
Pennant (PNTG) United States $0.789B 41.67
Aveanna Healthcare Holdings (AVAH) United States $0.677B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00